6164
H.-J. Lee et al. / Tetrahedron 57 (2001) 6155±6167
(B) By Zn/NaI reduction. Yield, 52 mg (68%); purity, 88.2%
143.4, 137.6, 132.9, 129.8, 127.9, 124.8, 120.1, 78.0, 44.9,
37.5, 36.9, 35.1, 35.0, 34.2, 29.9, 26.2, 22.5, 21.6, 21.2,
20.9, 20.8, 18.6, 17.9, 16.9; EIMS m/z 442.3 [M]1 (25),
255.2 (100), 227.2 (9), 213.2 (6), 185.1 (17), 149.1 (26),
91.1 (52); HREIMS m/z 442.2542 (calcd for C27H38O3S,
442.2542).
(GC); [a]20 22658 (c 0.52, CHCl3); UV (hexane) lmax
D
(log 1) 268 (3.93) nm; IR (neat) nmax 2956, 2868, 1669,
1617 (CvC), 1458, 1388, 1364, 862 cm21; EIMS m/z
272.3 [M]1 (90), 257.3 (48), 229.2 (28), 215.2 (2), 201.2
(6), 187.2 (14), 175.2 (8), 159.1 (15), 148.1 (56), 137.2 (88),
117.1 (30), 105.1 (58), 91.1 (100), 69.1 (57); HREIMS m/z
272.2503 (calcd for C20H32, 272.2504). See Tables 1 and 2
for NMR data.
4.2.18. 18-Iodopalustradiene (8). Reaction of tosylate 3e
(63.8 mg, 0.14 mmol) with Zn (94 mg, 1.44 mmol) and NaI
(108 mg, 0.72 mmol) for 16 h at 1008C, as described above
for 1b and similar puri®cation by chromatography with pen-
tane as eluant afforded iodide 8 (37.6 mg, 67%) as a color-
less oil: UV (hexane) lmax (log 1) 268 (3.96) nm; IR (neat)
nmax 2955, 2930, 2868, 1658 (CvC), 1467, 1380, 1212,
4.2.15. Methyl palustradien-18-oate (methyl palustrate,
methyl abieta-8,13-dien-18-oate, 3c). Yield, 209 mg
(100%); Lit.38b mp 24±278C; [a]20 1658 (c 1.60,
D
CHCl3) [Lit.52 [a]20 169.98 (c 2.09, CHCl3); Lit.38a,b
D
1
1678]; UV (hexane) lmax (log 1) 268 (3.95) nm; IR (neat)
nmax 2929, 2867, 1726 (CvO), 1660 (CvC), 1458, 1386,
1177, 861 cm21; H NMR (500 MHz, CDCl3) d 5.40 (1H,
s), 3.30 (1H, d, J9.9 Hz), 3.19 (1H, d, J9.9 Hz), 2.28
(1H, septet, J6.9 Hz), 2.22±1.97 (6H, m), 1.80 (1H, dt,
J12.9, 3.2 Hz), 1.64±1.50 (4H, m), 1.48 (1H, d,
J12.2 Hz), 1.41 (1H, td, J11.8, 5.6 Hz), 1.32 (2H, dd,
J8.8, 3.9 Hz), 1.03 (3H, s), 1.02 (3H, s), 1.01 (3H, s), 1.00
(3H, s); 13C NMR (125 MHz, CDCl3) d 143.3, 137.7, 124.9,
120.2, 48.5, 38.6, 37.7, 35.4, 35.3, 34.2, 30.1, 28.5, 26.2,
22.6, 21.2, 20.9, 20.3, 18.6, 18.4, 18.3; EIMS m/z 398.2
[M]1 (71), 383.1 (100), 369.0 (5), 306.2 (3), 291.2 (12),
271.3 (16), 256.2 (30), 241.2 (7), 213.2 (5), 188.2 (34),
173.1 (17), 149.1 (56), 123.1 (18), 105.1 (26), 91.1 (30),
69.1 (15); HREIMS m/z 398.1465 (calcd for C20H31I,
398.1470).
1
1249, 1170, 1112, 1038, 862 cm21; H NMR (500 MHz,
CDCl3) d 5.37 (1H, s), 3.64 (3H, s), 2.27 (1H, septet,
J6.8 Hz), 2.12±1.98 (7H, m), 1.83 (1H, d, J13.4 Hz),
1.72 (1H, dd, J11.5, 4.6 Hz), 1.66±1.53 (4H, m), 1.24±
1.19 (1H, m), 1.18 (3H, s), 1.15 (1H, td, J12.5, 4.2 Hz),
1.04 (3H, s), 1.01 (3H, s), 1.00 (3H, s); 13C NMR (125 MHz,
CDCl3) d 179.2, 143.4, 137.6, 124.9, 120.2, 51.8, 47.7, 46.2,
37.1, 36.6, 35.2, 34.3, 30.1, 26.2, 22.4, 21.6, 21.2, 21.0,
20.7, 18.2, 16.3; EIMS m/z 316.3 [M]1 (87), 301.3 (100),
273.2 (4), 257.3 (21), 241.2 (90), 227.2 (4), 213.2 (19),
199.2 (9), 185.2 (26), 173.2 (8), 149.1 (34), 128.1 (12),
117.1 (16), 105.1 (34), 91.1 (29), 79.1 (13); HREIMS m/z
316.2397 (calcd for C21H32O2, 316.2394). The UV data
agree with the literature values.38,52
4.2.19. Palustradiene (abieta-8,13-diene, 3b). Reductions
of iodide 8 (37.6 mg, 0.09 mmol) and tosylate 3e (85.1 mg,
0.19 mmol) with Zn/NaI in HMPA at 1058C for 1 and 2 d,
respectively, were carried out as described in Section 4.2.8.
The yields and purities were 18 mg (70% from 8, 95%
purity by GC) and 25 mg (48% from 3e, ca. 95% purity
4.2.16. Palustradien-18-ol (3d). Yield, 164 mg (99%); mp
130±1318C [Lit.51 mp 131±1328C]; [a]20 1508 (c 0.69,
D
CHCl3) [Lit.51 [a]20 1538 (c 2.64, CHCl3)]; H NMR
1
D
(500 MHz, CDCl3)
d
5.39 (1H, s), 3.43 (1H, d,
J10.3 Hz), 3.17 (1H, dd, J10.3, 4.5 Hz), 2.27 (1H,
septet, J6.6 Hz), 2.12±1.94 (5H, m), 1.82 (1H, broad t,
J12.6 Hz), 1.65 (1H, dt, J13.5, 3.9 Hz), 1.63±1.59
(2H, m), 1.55 (1H, dt, J14.1, 3.9 Hz), 1.46±1.42 (2H,
m), 1.38±1.29 (4H, m), 1.05 (3H, s), 1.02 (3H, s), 1.00
(3H, s), 0.80 (3H, s); 13C NMR (125 MHz, CDCl3) d
143.2, 138.2, 124.8, 120.2, 72.3, 45.3, 37.6, 37.5, 35.5,
35.0, 34.2, 30.3, 26.2, 22.6, 21.2, 21.0, 20.9, 18.6, 18.3,
17.3; EIMS m/z 288.3 [M]1 (56), 273.2 (100), 255.2 (20),
227.2 (9), 213.2 (6), 199.2 (10), 188.2 (5), 173.1 (13), 161.2
(16), 149.1 (38), 133.1 (21), 105.1 (30), 91.1 (26), 67.1 (13);
HREIMS m/z 288.2454 (calcd for C20H32O, 288.2453). UV,
by 1H NMR estimate): [a]20 1598 (c 0.72, CHCl3)
D
[Lit.13 [a]20 2688 (c 5.00), Lit.12 245.58 (CHCl3)]; UV
D
(hexane) lmax (log 1) 268 (3.95) nm [Lit.13 lmax 267 (3.92,
heptane) nm]; IR (neat) nmax 2958, 2933, 2865, 1673
(CvC), 1457, 1370, 862 cm21; EIMS m/z 272.3 [M]1
(33), 257.3 (100), 243.1 (2), 229.2 (9), 214.2 (4), 188.2
(5), 173.2 (7), 161.2 (12), 149.2 (23), 133.1 (13), 117.1
(9), 107.1 (11), 91.1 (16), 81.1 (8), 69.1 (25); HREIMS
m/z 272.2510 (calcd for C20H32, 272.2504). See Tables 1
and 2 for NMR data.
1
4.2.20. Logic used to assign H and 13C NMR data for
palustradiene (3b). The H NMR singlets for the three
1
1
IR, and limited H NMR data are available in the litera-
ture.51
quaternary methyl groups on ring A (dH 0.89, 0.86, 1.06)
were identi®ed with C18, C19, and C20, respectively, by the
NOE results presented in Table 3. Although irradiations
intended for one of the gem dimethyl groups inevitably
excited both, the distinctive NOEs observed at dH 1.06±
2.08 (H11b, 3.2%) and 0.86 (H19, 7.8%) from selective
irradiation at 1.06 (H20) allowed unambiguous assignments
of C20 and C19, and by process of elimination C18. These
methyl peaks were correlated with 13C NMR signals at dC
33.4 and 21.5±21.7 by HMQC cross peaks, but overlap of
the higher ®eld pair left the assignments to C19 and C20
ambiguous. The low ®eld position of the equatorial methyl
(C18, 33.4) in palustradiene is consistent with its location in
the 13C NMR spectra of the other 3 dienes (dC 33.5±33.8).
However, its proximity (DdC 0.02) to the signal for C4
4.2.17. Palustradien-18-yl p-toluenesulfonate (3e). The
tosylate was prepared by the procedure described for 2e.
Data for 3e: yield, 189 mg (85%); mp 68±698C;
[a]20 1618 (c 0.33, CHCl3); UV (hexane) lmax (log 1)
D
266 (4.01) nm; IR (thin ®lm) nmax 2956, 2871, 1658
(CvC), 1599, 1459, 1358, 1189, 1099, 965, 844,
1
814 cm21; H NMR (500 MHz, CDCl3) d 7.76 (2H, d,
J8.4 Hz), 7.33 (2H, d, J8.6 Hz), 5.36 (1H, s), 3.73
(1H, d, J9.2 Hz), 3.55 (1H, d, J9.2 Hz), 2.45 (3H, s),
2.27 (1H, septet, J6.9 Hz), 2.07±1.95 (6H, m), 1.78 (1H,
dt, J12.6, 3.0 Hz), 1.59 (1H, dt, J13.5, 3.9 Hz), 1.51 (1H,
dt, J13.9, 3.6 Hz), 1.46±1.26 (6H, m), 1.02 (3H, s), 1.00
(6H, s), 0.79 (3H, s); 13C NMR (125 MHz, CDCl3) d 144.6,